Navigation Links
XTENT Announces Clinical Trial Data to be Presented at Annual EuroPCR Meeting Next Week
Date:5/7/2008

Webcast to Review CUSTOM III Six-Month Data to be held Tuesday, May 13th

MENLO PARK, Calif., May 7 /PRNewswire-FirstCall/ -- XTENT, Inc. (Nasdaq: XTNT) today announced that six-month follow-up data from the CUSTOM III trial will be presented at EuroPCR, taking place May 13 to 16 in Barcelona. The company will hold a webcast and conference call to review the new CUSTOM III data immediately following the late-breaking session. In addition, two-year CUSTOM I data, previously presented at the Transcatheter Cardiovascular Therapeutics (TCT) meeting last October, has been accepted for publication in the May issue of EuroIntervention. Professor Grube, the CUSTOM I principal investigator, has been asked to present the data during a EuroPCR session on the six best papers from EuroIntervention. XTENT is also sponsoring an evening symposium on customizable drug-eluting stents and will exhibit throughout the meeting at booth E11 in the main hall.

Schedule of XTENT Events for EuroPCR

Tuesday, May 13, 2008, 3:30-6:30 p.m. CEST, Room 1

Late-Breaking Clinical Trial: CUSTOM III trial 6-month follow-up results.

Bernard de Bruyne, M.D., Ph.D, Cardiovascular Center, OLV Hospital in Aalst, Belgium, the principal investigator of the CUSTOM III clinical trial, will present six-month follow-up data from the CUSTOM III trial evaluating use of the Custom NX(R) Drug Eluting Stent (DES) System in patients with long or multiple coronary lesions.

Tuesday, May 13, 2008, 7:00 p.m. CEST (1:00 p.m. EDT)

CUSTOM III webcast and conference call.

To participate in the conference call, please dial 877-591-4957 (from the U.S.) or 719-325-4895 (international). The webcast and slide presentation can be accessed via the in
'/>"/>

SOURCE XTENT, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. XTENT to Present CUSTOM I and CUSTOM II Trial Data at TCT 2007
2. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
3. Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis
4. XTENT Announces First Quarter 2008 Financial Results
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... , June 17, 2013 The ... first portable, hand held device for the non-invasive ... the human body. It replaces expensive, time consuming ... of a button, the Biozoom scanner reflects a ... Carl Zeiss—and measures the reflection. Using the scanner, ...
(Date:6/17/2013)... TEL AVIV, Israel , June 17, 2013 /PRNewswire/ ... 2013, the Board of Governors of the Israel-U.S. Binational ... $10.95 million in funding for fourteen new projects between ... from BIRD , the projects will access private ... to approximately $33 million. The semi-annual meeting was held ...
(Date:6/17/2013)... , June 17, 2013 Perrigo Company ... it has signed a definitive agreement to acquire and ... and solution product portfolio from Fera Pharmaceuticals, LLC and ... New York -based specialty pharmaceutical company. The acquired ... $30 million in net revenues during calendar year 2012. ...
Breaking Medicine Technology:University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work 2University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work 3University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work 4BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 2BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 3BIRD - Israel - U.S. Binational Industrial R&D Foundation to Invest $11 Million in 14 new Projects 4Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharmaceuticals, LLC For An Upfront Payment Of $93 Million 2Perrigo Company Acquires Ophthalmic Product Portfolio From Fera Pharmaceuticals, LLC For An Upfront Payment Of $93 Million 3
... Inc. (Nasdaq: ECTE ), a company developing ... continuous glucose monitoring (tCGM) system and the Prelude® SkinPrep ... is initiating clinical studies of its Symphony tCGM System ... and announce the results of the studies in the ...
...   OncoSec Medical Inc. (OTCBB:ONCS), which is ... (OMS) ElectroOncology therapies to treat solid tumor cancers, ... Officer at OncoSec, will be presenting at the ... 25-26, 2012. (Logo:  http://photos.prnewswire.com/prnh/20110314/MM64943LOGO ) ...
Cached Medicine Technology:Echo Therapeutics Initiates Clinical Trials of its Symphony tCGM System in Critical Care Patients 2Echo Therapeutics Initiates Clinical Trials of its Symphony tCGM System in Critical Care Patients 3OncoSec to Present at World Cancer Immunotherapy Conference 2OncoSec to Present at World Cancer Immunotherapy Conference 3
(Date:6/17/2013)... June 18, 2013 For the ... listed in New York magazine's annual "Best Doctors" ... survey, 209 NewYork-Presbyterian physicians from 55 specialties were ... some of the nation's best physicians right in ... of NewYork-Presbyterian Hospital. "We are thrilled to have ...
(Date:6/17/2013)... Ill. In a study of more than 2,000 ... abdominal aorta the amount of plaque in the ... associated with future cardiovascular events, such as a heart ... online in the journal Radiology . , "This ... in an artery outside the heart is an independent ...
(Date:6/17/2013)... media initiative helped to boost organ donor registration rates, ... American Journal of Transplantation . The findings suggest that ... a variety of problems related to public health in ... donation rates in the United States have remained static ... each year. To provide organs to the more than ...
(Date:6/17/2013)... CO (PRWEB) June 17, 2013 Daily ... will, therefore, publish a thorough review of the ... , Daily Gossip presents the natural treatment ... on patients who have tested it. , Based on ... the natural Tinnitus treatment suggested by Thomas ...
(Date:6/17/2013)... Tempe, AZ (PRWEB) June 17, 2013 Bust’DD ... are both stylish and well-fitting to women with large busts, ... is founded by two women who understand the problem of ... to other busty women. Their goal is to raise at ... end goal of offering their bras on a wide scale. ...
Breaking Medicine News(10 mins):Health News:NewYork-Presbyterian Leads NY Metro Area Hospitals on New York Magazine's Annual ‘Best Doctors' List 2Health News:Atherosclerosis in abdominal aorta may signal future heart attack, stroke 2Health News:Social media initiative may help increase organ donations 2Health News:Thomas Coleman's Tinnitus Miracle Treatment Review Discloses Alternative Natural Cure 2Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 2Health News:Arizona Startup Bust’DD Looking to Start a BRAvolution 3
... FRANCISCO A further analysis of a previously published ... study of children with mild persistent asthma reports the ... children with differing demographic and clinical characteristics. ... in the TReating Children to Prevent Exacerbations of Asthma ...
... flu shot during pregnancy provides unanticipated benefits to the ... study examining the issue. Specifically, the study showed that ... significantly reduced risk of stillbirth, preterm birth and extremely ... Hospital Research Institute (OHRI), the CHEO Research Institute and ...
... , MONDAY, May 21 (HealthDay News) -- In a scenario ... found a way to perform nearly surgery-free gastric bypass procedures ... done with moveable magnets, is completed in less than a ... leaving behind any foreign material. Although pigs may not ...
... By Jenifer Goodwin HealthDay Reporter , MONDAY, ... used in some artificial sweeteners, may worsen Crohn,s disease by ... intestine, a new study suggests. However, researchers stressed that ... the lab, not in people, so it,s too soon to ...
... including a scientist from the Viral Immunology Center at ... herpesvirus infection of the eye is associated with neovascular ... in the elderly. The scientists found that human ... vascular endothelial growth factor, or VEGF, a signal protein ...
... to see that University of Cincinnati design students Alex Broerman ... design and prototype for a prescription-medicine pill bottle that better ... means of a simple and inexpensive innovation. In fact, ... their design a design intended to have universal appeal ...
Cached Medicine News:Health News:Baseline characteristics of children with mild persistent asthma predict response to ICS 2Health News:Flu shot during pregnancy shows unexpected benefits in large study 2Health News:Moveable Magnets Used to Forge Gastric Bypass in Pigs 2Health News:Moveable Magnets Used to Forge Gastric Bypass in Pigs 3Health News:Could Compound in Artificial Sweeteners Worsen Crohn's Disease? 2Health News:Could Compound in Artificial Sweeteners Worsen Crohn's Disease? 3Health News:Type of viral infection of eye associated with disease causing blindness in the elderly 2Health News:UC students design a better pill bottle for the blind and visually impaired 2Health News:UC students design a better pill bottle for the blind and visually impaired 3
... The QuickVue Influenza A+B test allows ... influenza type A and type B ... wash and/or nasal aspirate specimens. The ... in the rapid differential diagnosis of ...
... Antibody Detection Assay is a single use, ... (first step) detection of IgG and IgM ... or whole blood. Rapid turnaround time, ease ... Wampole PreVue B. burgdorferi antibody detection test ...
... Conforming to U.S. and international ... Nephew's TC-100 Screw and Plating System* ... and ease of use for open ... However, the TC-100 system works well ...
Comprehensive range of integrated implants and instruments including - Basic, Small, Mini, Pelvic and Foot Sets....
Medicine Products: